|
|
|
 |
| Location: Home -
Products - Active Pharma Ingredients(API) - Peptide APIs
|
Glatiramer acetate(Copolymer 1)
| Catalogue No. : |
C14803 |
| Product Name: |
Glatiramer acetate(Copolymer 1) |
| Synonym: |
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt);511: PN: WO2010103292 PAGE: 64 claimed sequence; Cop 1; Copaxone; Copolymer 1;L-Glutamic Acid peptide with L-Alanine L-Lysine L-Tyrosine Acetate Salt;Protiramer;TV 5010 |
| Chemical Name: |
L-Alanine polymer with L-Glutamic Acid L-Lysine L-Tyrosine Acetate ; L-Tyrosine polymer with L-Alanine L-Glutamic Acid L-Lysine Acetate |
| CAS No. : |
147245-92-9 |
| Structure : |
|
| Molecular Formula: |
C25H45N5O13 |
| Molecular Weight: |
623.65 |
| Usage: |
Glatiramer acetate is a random basic synthetic copolymer of L-alanine, L-lysine, l-glutamic acid and L-tyrosine in a molar ratio of 6:1.9:4.7:1. Glatiramer acetate is an immunomodulator used in treatment of multiple sclerosis. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
